APRIL WYMA: Open Payments
NPI 1649743683 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,356 in 166 payments from 21 companies in 2025. Trend: 2023 $1,723 · 2024 $2,568 · 2025 $3,356
Food & beverage: $3,156Education: $200
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 17 | $463 |
| Janssen Biotech, Inc. | 17 | $386 |
| LEO Pharma Inc. | 21 | $331 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $249 |
| PFIZER INC. | 10 | $243 |
| UCB, Inc. | 11 | $225 |
| ABBVIE INC. | 15 | $222 |
| Novartis Pharmaceuticals Corporation | 11 | $213 |
| Galderma Laboratories, L.P. | 11 | $159 |
| Incyte Corporation | 7 | $155 |
Products named: TREMFYA, DUPIXENT, ADBRY, CIBINQO, Bimzelx, SKYRIZI, OPZELURA, NEMLUVIO.
Industry payments across AZ — which companies pay providers there.
